Analyst Reco. Bruker Corporation

Stocks

BRKR

US1167941087

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 17:45:53 11/06/2026 BST			5-day change	1st Jan Change
53.90 ^USD	-1.87%		-9.97%	+14.60%

06-08	Bruker Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 11:40 AM
06-04	Bruker Corporation Showcases Expanding Microbiology and Infection Diagnostics Portfolio at ASM Microbe 2026	CI

Analyst Reco.

06-02	BofA Securities Adjusts Bruker Price Target to $65 From $49	MT
05-07	UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating	MT
02-13	UBS Adjusts Price Target on Bruker to $40 From $43, Maintains Neutral Rating	MT
12-10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT
11-20	Rothschild & Co Redburn Initiates Coverage on Bruker With Buy Rating, $60 Price Target	MT
11-04	UBS Adjusts Price Target on Bruker to $43 From $40, Maintains Neutral Rating	MT
11-03	(BRKR) Bruker Expects 2025 Non-GAAP EPS Range $1.85 to $1.90, vs. FactSet Est of $1.93	MT
11-03	Certain Restricted Stock Units of Bruker Corporation are subject to a Lock-Up Agreement Ending on 3-NOV-2025.	CI
22/05/25	Citigroup Downgrades Bruker to Neutral From Buy, Lowers Price Target to $40 From $50	MT
08/05/25	UBS Cuts Price Target on Bruker to $45 From $57, Keeps Neutral Rating	MT
14/04/25	BofA Securities Lowers Bruker Price Target to $61 From $76	MT
19/12/24	Guggenheim Initiates Coverage on Bruker With Buy Rating, $72 Price Target	MT
10/12/24	UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102	MT
05/12/24	Goldman Sachs Upgrades Bruker to Neutral From Sell, Price Target is $60	MT
30/09/24	Wolfe Research Downgrades Bruker to Peer Perform From Outperform	MT
09/07/24	Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	MT
20/05/24	Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating	MT
10/04/24	Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	MT
01/03/24	UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	MT
15/02/24	UBS Adjusts Bruker Price Target to $94 From $86, Maintains Buy Rating	MT
14/02/24	TD Cowen Adjusts Bruker's Price Target to $84 From $75, Keeps Market Perform Rating	MT
14/02/24	Stifel Adjusts Bruker's Price Target to $81 From $63, Keeps Hold Rating	MT
14/02/24	Leerink Partners Adjusts Bruker's Price Target to $90 From $86, Keeps Outperform Rating	MT
14/02/24	Citigroup Adjusts Bruker's Price Target to $95 From $80, Keeps Buy Rating	MT
14/02/24	Jefferies Adjusts Bruker's Price Target to $90 From $72, Keeps Buy Rating	MT